Deymeer F - Search Results

1

Natural history of SMA IIIb: muscle strength decreases in a predictable sequence and magnitude.

Deymeer F, Serdaroglu P, Parman Y, Poda M. Deymeer F, et al. Neurology. 2008 Aug 26;71(9):644-9. doi: 10.1212/01.wnl.0000324623.89105.c4. Neurology. 2008. PMID: 18725590

2

Segmental distribution of muscle weakness in SMA III: implications for deterioration in muscle strength with time.

Deymeer F, Serdaroğlu P, Poda M, Gülşen-Parman Y, Ozçelik T, Ozdemir C. Deymeer F, et al. Neuromuscul Disord. 1997 Dec;7(8):521-8. doi: 10.1016/s0960-8966(97)00113-2. Neuromuscul Disord. 1997. PMID: 9447610 Clinical Trial.

3

Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients.

Durmus H, Laval SH, Deymeer F, Parman Y, Kiyan E, Gokyigiti M, Ertekin C, Ercan I, Solakoglu S, Karcagi V, Straub V, Bushby K, Lochmüller H, Serdaroglu-Oflazer P. Durmus H, et al. Among authors: deymeer f. Neurology. 2011 Jan 18;76(3):227-35. doi: 10.1212/WNL.0b013e318207b043. Neurology. 2011. PMID: 21242490

4

Clinicopathological and genetic study of early-onset demyelinating neuropathy.

Parman Y, Battaloglu E, Baris I, Bilir B, Poyraz M, Bissar-Tadmouri N, Williams A, Ammar N, Nelis E, Timmerman V, De Jonghe P, Najafov A, Deymeer F, Serdaroglu P, Brophy PJ, Said G. Parman Y, et al. Among authors: deymeer f. Brain. 2004 Nov;127(Pt 11):2540-50. doi: 10.1093/brain/awh275. Epub 2004 Oct 6. Brain. 2004. PMID: 15469949

5

Neuromuscular endplate pathology in recessive desminopathies: Lessons from man and mice.

Durmuş H, Ayhan Ö, Çırak S, Deymeer F, Parman Y, Franke A, Eiber N, Chevessier F, Schlötzer-Schrehardt U, Clemen CS, Hashemolhosseini S, Schröder R, Hemmrich-Stanisak G, Tolun A, Serdaroğlu-Oflazer P. Durmuş H, et al. Among authors: deymeer f. Neurology. 2016 Aug 23;87(8):799-805. doi: 10.1212/WNL.0000000000003004. Epub 2016 Jul 20. Neurology. 2016. PMID: 27440146

6

Transient weakness and compound muscle action potential decrement in myotonia congenita.

Deymeer F, Cakirkaya S, Serdaroğlu P, Schleithoff L, Lehmann-Horn F, Rüdel R, Ozdemir C. Deymeer F, et al. Muscle Nerve. 1998 Oct;21(10):1334-7. doi: 10.1002/(sici)1097-4598(199810)21:10<1334::aid-mus16>3.0.co;2-1. Muscle Nerve. 1998. PMID: 9736066

7

Absence of KIF1B mutation in a large Turkish CMT2A family suggests involvement of a second gene.

Bissar-Tadmouri N, Nelis E, Züchner S, Parman Y, Deymeer F, Serdaroglu P, De Jonghe P, Van Gerwen V, Timmerman V, Schröder JM, Battaloglu E. Bissar-Tadmouri N, et al. Among authors: deymeer f. Neurology. 2004 May 11;62(9):1522-5. doi: 10.1212/01.wnl.0000123253.57555.3a. Neurology. 2004. PMID: 15136675

8

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.

Deymeer F, Gungor-Tuncer O, Yilmaz V, Parman Y, Serdaroglu P, Ozdemir C, Vincent A, Saruhan-Direskeneli G. Deymeer F, et al. Neurology. 2007 Feb 20;68(8):609-11. doi: 10.1212/01.wnl.0000254620.45529.97. Neurology. 2007. PMID: 17310034

9

HLA-DQ polymorphism in Turkish patients with myasthenia gravis.

Saruhan-Direskeneli G, Kiliç A, Parman Y, Serdaroğlu P, Deymeer F. Saruhan-Direskeneli G, et al. Among authors: deymeer f. Hum Immunol. 2006 Apr-May;67(4-5):352-8. doi: 10.1016/j.humimm.2006.02.039. Epub 2006 Apr 7. Hum Immunol. 2006. PMID: 16720217

10

Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis.

Baslo MB, Deymeer F, Serdaroglu P, Parman Y, Ozdemir C, Cuttini M. Baslo MB, et al. Among authors: deymeer f. Neuromuscul Disord. 2006 Jul;16(7):454-8. doi: 10.1016/j.nmd.2006.05.009. Epub 2006 Jun 30. Neuromuscul Disord. 2006. PMID: 16806929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters